MSR1 and prostate carcinoma: Additionally, MSR1 (a tumour suppressor in prostate cancer [65] and chronic myeloid leukaemia [66]) presented the most suggestive trans association, downregulated by a somatic eQTL positioned 1.5 Mb downstream (P = 0.009, FDR ≤ 0.3).